(Q38357717)

2 September 2017

1 reference

title

Early detection of colorectal cancer: from conventional methods to novel biomarkers (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Nasimeh Vatandoost

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Jahanafrooz Ghanbari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mahboobeh Mojaver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Amir Avan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Majid Ghayour-Mobarhan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Rasoul Salehi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

17 February 2015

1 reference

Journal of Cancer Research and Clinical Oncology

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

341-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687380%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-015-1928-z

3 June 2020

exact match

0 references

cites work

A miRNA-binding site single nucleotide polymorphism in the 3'-UTR region of the NOD2 gene is associated with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Phylogenetic shadowing and computational identification of human microRNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Genetic and epigenetic traits as biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Polymorphisms in microRNA targets: a gold mine for molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Autoantibody signatures: progress and perspectives for early cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Detecting colorectal cancer in stool with the use of multiple genetic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Detection of colon polyps by a novel, polymer pattern-based full blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Detection of microRNA expression in human peripheral blood microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Fecal molecular markers for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Noninvasive molecular biomarkers for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

The diverse functions of microRNAs in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Fecal MicroRNAs as novel biomarkers for colon cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

MicroRNAs in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

An overview of colorectal cancer survival rates and prognosis in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Noninvasive testing for colorectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Colon cancer screening: which non-invasive filter tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Human polymorphism at microRNAs and microRNA target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Epigenetics Offer New Horizons for Colorectal Cancer Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Urinary prostaglandin E2 metabolite and risk for colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Serum autoantibodies as biomarkers for early cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Biomarkers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Performance improvements of stool-based screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

The frequency of hypertension crises in the emergency medical service department in tuzla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Future directions for monitoring treatment response in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Advances in epigenetic biomarker research in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A plasma microRNA panel for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1928-Z

A simplified, noninvasive stool DNA test for colorectal cancer detection

21 January 2018

1 reference

12 December 2020

Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer

1 reference

12 December 2020

Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer

1 reference

12 December 2020

[Nationwide colorectal cancer screening]

1 reference

12 December 2020

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle

1 reference

12 December 2020

The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening

1 reference

12 December 2020

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

1 reference

12 December 2020

Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer.

1 reference

12 December 2020

Multiple serological biomarkers for colorectal cancer detection

1 reference

12 December 2020

Stool test for colorectal cancer screening--it's time to move!

1 reference

12 December 2020

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

1 reference

12 December 2020

Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer

1 reference

12 December 2020

Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk

1 reference

12 December 2020

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer

1 reference

12 December 2020

Prognostic and predictive molecular markers in colorectal carcinoma.

1 reference

12 December 2020

Plasma miR-21: a potential diagnostic marker of colorectal cancer

1 reference

12 December 2020

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

1 reference

12 December 2020

Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?

1 reference

12 December 2020

DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population.

1 reference

12 December 2020

Colorectal cancer screening

1 reference

12 December 2020

A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma

1 reference

12 December 2020